Ticker
ACRVCompany Name
ACRIVON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | 0% | $ 41.21M | $ 1K |
3/31/2025 | -363.72% | $ 35.75M | $ 130.01M |
12/31/2024 | -164.66% | $ 79.01M | $ 130.09M |
9/30/2024 | -52.82% | $ 246.91M | $ 130.41M |
6/30/2024 | -58.11% | $ 224.55M | $ 130.49M |
3/31/2024 | -0.33% | $ 258.13M | $ 854K |
12/31/2023 | -0.48% | $ 161.85M | $ 775K |
9/30/2023 | -100.27% | $ 101.87M | $ 102.14M |
6/30/2023 | -37.33% | $ 273.48M | $ 102.09M |
3/31/2023 | 0% | $ 297.54M | $ 0 |
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for ACRIVON THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 1K ]) / Market Cap [ $ 0 ]
(=) Buyback Yield [ 0% ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.46% |
average | 0.64% |
median | 0.01% |
std | 2.71% |